Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00066118 · ClinicalTrials.gov registry record · Phase 3

Health Effects of Silver-Mercury Dental Fillings

A Phase 3 study, sponsored by University of Washington.

Completed
Registry status
Phase 3
Development phase
507
Enrollment target

NCT00066118 is a Phase 3 study that has completed, run by University of Washington. The registered enrollment target is 507 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00066118, a Phase 3 study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
Phase 3
Development phase
507 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether there are detectable health effects of low-level mercury exposure (from normal exposure to mercury-containing dental fillings) in the known target organs/systems affected by elemental mercury exposure.

Interventions

  • DEVICE Dental amalgam restorations

Trial Details

FieldValue
Enrollment Target 507 participants
Start Date 1996-08
Est. Completion 2011-02
Phase Phase 3

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT00066118

The ClinicalTrials.gov registry entry for NCT00066118 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 507 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dental amalgam restorations is the first listed.

NCT00066118 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00066118 about?

NCT00066118 is a clinical study titled "Health Effects of Silver-Mercury Dental Fillings". The purpose of this study is to determine whether there are detectable health effects of low-level mercury exposure (from normal exposure to mercury-containing dental fillings) in the known target organs/systems affected by elemental mercury exposure.

What is the current status of trial NCT00066118?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 507 participants. The study started on 1996-08. Estimated completion is 2011-02.

What interventions are being tested in trial NCT00066118?

The interventions under investigation include: Dental amalgam restorations (DEVICE).

Who is sponsoring clinical trial NCT00066118?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.